Abstract

Petite Integration Factor 1 (PIF1) is a multifunctional helicase present in nuclei and mitochondria. PIF1 knock out (KO) mice exhibit accelerated weight gain and decreased wheel running on a normal chow diet. In the current study, we investigated whether Pif1 ablation alters whole body metabolism in response to weight gain. PIF1 KO and wild type (WT) C57BL/6J mice were fed a Western diet (WD) rich in fat and carbohydrates before evaluation of their metabolic phenotype. Compared with weight gain-resistant WT female mice, WD-fed PIF1 KO females, but not males, showed accelerated adipose deposition, decreased locomotor activity, and reduced whole-body energy expenditure without increased dietary intake. Surprisingly, PIF1 KO females did not show obesity-induced alterations in fasting blood glucose and glucose clearance. WD-fed PIF1 KO females developed mild hepatic steatosis and associated changes in liver gene expression that were absent in weight-matched, WD-fed female controls, linking hepatic steatosis to Pif1 ablation rather than increased body weight. WD-fed PIF1 KO females also showed decreased expression of inflammation-associated genes in adipose tissue. Collectively, these data separated weight gain from inflammation and impaired glucose homeostasis. They also support a role for Pif1 in weight gain resistance and liver metabolic dysregulation during nutrient stress.

Highlights

  • The increasing prevalence of obesity is a global public health problem, which has been striking among children and adolescents in both developed and developing countries [1]

  • As the weight of Western diet (WD)-fed Petite Integration Factor 1 (PIF1) knock out (KO) females diverged from wild type (WT) females, we focused exclusively on the female cohort in subsequent experiments

  • While we have previously shown that Petite Integration Frequency 1 helicase knockout (PIF1 KO) mice gain weight on a regular chow diet, it was not known whether PIF1 KO mice develop metabolic alterations under WD-induced weight gain

Read more

Summary

Introduction

The increasing prevalence of obesity is a global public health problem, which has been striking among children and adolescents in both developed and developing countries [1]. Clinical complications of obesity include metabolic syndrome, which can progress to type 2 diabetes mellitus (T2DM) and cardiovascular disease. Current understanding of the genes involved in obesity is limited, despite its high heritability [2]. 90% of patients with T2DM are overweight or obese. While being overweight greatly increases the likelihood of developing T2DM [3], only a subset of obese individuals acquires T2DM. Factors such as tissue inflammation that drive obesity or that determine the diabetic phenotype in obese individuals are poorly understood

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.